From the Department of Surgery, Indiana University, Indianapolis, IN (Ceppa, Kim, House, Nakeeb)
Biostatistics Shared Resource (Lowe), Duke University Medical Center, Durham, NC.
Department of Biostatistics and Bioinformatics (Niedzwiecki), Duke University Medical Center, Durham, NC.
Duke Cancer Institute (Warren, Moyer), Duke University Medical Center, Durham, NC.
Department of Surgery (Zani, Blazer), Duke University Medical Center, Durham, NC.
Received December 12, 2022; Accepted December 13, 2022.
Investigators from the Closed Incision Negative Pressure Therapy group who coauthored this article are given in the Appendix.
Disclosure Information: This trial was funded by 3M Health Care (previously Kinetic Concepts USA, Inc).
Disclosures outside the scope of this work: Dr Niedzwiecki is supported by funding to Duke University from the Prevena Incision Management System (3M Health Care).
Presented at the Southern Surgical Association 134th Annual Meeting, Palm Beach, FL, December 2022.
Clinical Trial Registration: NCT01905397.
Correspondence address: Dan G Blazer III, MD, FACS, DUMC 3247, Durham, NC 27710. email: [email protected]